These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 28252048)
21. Correlation of Utrophin Levels with the Dystrophin Protein Complex and Muscle Fibre Regeneration in Duchenne and Becker Muscular Dystrophy Muscle Biopsies. Janghra N; Morgan JE; Sewry CA; Wilson FX; Davies KE; Muntoni F; Tinsley J PLoS One; 2016; 11(3):e0150818. PubMed ID: 26974331 [TBL] [Abstract][Full Text] [Related]
22. Increased constitutive nitric oxide production by whole body periodic acceleration ameliorates alterations in cardiomyocytes associated with utrophin/dystrophin deficiency. Lopez JR; Kolster J; Zhang R; Adams J J Mol Cell Cardiol; 2017 Jul; 108():149-157. PubMed ID: 28623080 [TBL] [Abstract][Full Text] [Related]
23. The role of utrophin in the potential therapy of Duchenne muscular dystrophy. Perkins KJ; Davies KE Neuromuscul Disord; 2002 Oct; 12 Suppl 1():S78-89. PubMed ID: 12206801 [TBL] [Abstract][Full Text] [Related]
24. Celecoxib treatment improves muscle function in mdx mice and increases utrophin A expression. Péladeau C; Adam NJ; Jasmin BJ FASEB J; 2018 Sep; 32(9):5090-5103. PubMed ID: 29723037 [TBL] [Abstract][Full Text] [Related]
25. iNOS expression in dystrophinopathies can be reduced by somatic gene transfer of dystrophin or utrophin. Louboutin JP; Rouger K; Tinsley JM; Halldorson J; Wilson JM Mol Med; 2001 May; 7(5):355-64. PubMed ID: 11474581 [TBL] [Abstract][Full Text] [Related]
27. Harnessing the potential of dystrophin-related proteins for ameliorating Duchenne's muscular dystrophy. Krag TO; Gyrd-Hansen M; Khurana TS Acta Physiol Scand; 2001 Mar; 171(3):349-58. PubMed ID: 11412148 [TBL] [Abstract][Full Text] [Related]
28. Interleukin-6 and neuregulin-1 as regulators of utrophin expression via the activation of NRG-1/ErbB signaling pathway in mdx cells. Juretić N; Díaz J; Romero F; González G; Jaimovich E; Riveros N Biochim Biophys Acta Mol Basis Dis; 2017 Mar; 1863(3):770-780. PubMed ID: 27988307 [TBL] [Abstract][Full Text] [Related]
29. Nitric oxide and l-arginine cause an accumulation of utrophin at the sarcolemma: a possible compensation for dystrophin loss in Duchenne muscular dystrophy. Chaubourt E; Fossier P; Baux G; Leprince C; Israël M; De La Porte S Neurobiol Dis; 1999 Dec; 6(6):499-507. PubMed ID: 10600405 [TBL] [Abstract][Full Text] [Related]
31. [Utrophin, a way to cure Duchenne muscle dystrophy]. Gillis JM Med Sci (Paris); 2004 Apr; 20(4):442-7. PubMed ID: 15124117 [TBL] [Abstract][Full Text] [Related]
32. Pharmacological activation of PPARbeta/delta stimulates utrophin A expression in skeletal muscle fibers and restores sarcolemmal integrity in mature mdx mice. Miura P; Chakkalakal JV; Boudreault L; Bélanger G; Hébert RL; Renaud JM; Jasmin BJ Hum Mol Genet; 2009 Dec; 18(23):4640-9. PubMed ID: 19744959 [TBL] [Abstract][Full Text] [Related]
33. Utrophin A is essential in mediating the functional adaptations of mdx mouse muscle following chronic AMPK activation. Al-Rewashdy H; Ljubicic V; Lin W; Renaud JM; Jasmin BJ Hum Mol Genet; 2015 Mar; 24(5):1243-55. PubMed ID: 25324540 [TBL] [Abstract][Full Text] [Related]
34. SERCA1 overexpression minimizes skeletal muscle damage in dystrophic mouse models. Mázala DA; Pratt SJP; Chen D; Molkentin JD; Lovering RM; Chin ER Am J Physiol Cell Physiol; 2015 May; 308(9):C699-709. PubMed ID: 25652448 [TBL] [Abstract][Full Text] [Related]
35. Comparison of skeletal muscle pathology and motor function of dystrophin and utrophin deficient mouse strains. van Putten M; Kumar D; Hulsker M; Hoogaars WM; Plomp JJ; van Opstal A; van Iterson M; Admiraal P; van Ommen GJ; 't Hoen PA; Aartsma-Rus A Neuromuscul Disord; 2012 May; 22(5):406-17. PubMed ID: 22284942 [TBL] [Abstract][Full Text] [Related]
36. Characterization of neuromuscular synapse function abnormalities in multiple Duchenne muscular dystrophy mouse models. van der Pijl EM; van Putten M; Niks EH; Verschuuren JJ; Aartsma-Rus A; Plomp JJ Eur J Neurosci; 2016 Jun; 43(12):1623-35. PubMed ID: 27037492 [TBL] [Abstract][Full Text] [Related]
37. Utrophin haploinsufficiency does not worsen the functional performance, resistance to eccentric contractions and force production of dystrophic mice. Boulanger Piette A; Hamoudi D; Marcadet L; Kyomi Labelle F; Ovidiu David R; Bossé S; Argaw A; Frenette J PLoS One; 2018; 13(6):e0198408. PubMed ID: 29879154 [TBL] [Abstract][Full Text] [Related]
38. Utrophin upregulation for treating Duchenne or Becker muscular dystrophy: how close are we? Miura P; Jasmin BJ Trends Mol Med; 2006 Mar; 12(3):122-9. PubMed ID: 16443393 [TBL] [Abstract][Full Text] [Related]
39. Expression of a NOS transgene in dystrophin-deficient muscle reduces muscle membrane damage without increasing the expression of membrane-associated cytoskeletal proteins. Tidball JG; Wehling-Henricks M Mol Genet Metab; 2004 Aug; 82(4):312-20. PubMed ID: 15308129 [TBL] [Abstract][Full Text] [Related]